Pivotal bioVenture Partners Fund I L.P. insider trades

Open-market stock purchases and sales by Pivotal bioVenture Partners Fund I L.P., Director, 10% Owner at Evommune, Inc, from SEC Form 4 filings since Sep 28, 2018.

Track record: 25% of 4 scored buys are up 5% or more since purchase, averaging -25%.

Recent trades

DateStockTradeValue
Nov 7, 2025EVMN Evommune, IncBought (not open market)—
Nov 7, 2025EVMN Evommune, IncBought (not open market)—
Nov 7, 2025EVMN Evommune, IncBought (not open market)—
Nov 7, 2025EVMN Evommune, IncBought (not open market)—
Nov 7, 2025EVMN Evommune, IncBought (not open market)—
Nov 7, 2025EVMN Evommune, IncBought (not open market)—
Nov 7, 2025EVMN Evommune, IncBought (not open market)—
Nov 7, 2025EVMN Evommune, IncBought (not open market)—
Nov 7, 2025EVMN Evommune, IncBought (not open market)—
Nov 7, 2025EVMN Evommune, IncBought (not open market)—
Nov 7, 2025EVMN Evommune, IncBought (not open market)—

Companies traded

  • EVMN Evommune, Inc: other filings, last Nov 7, 2025
  • INZY Inozyme Pharma, Inc: 4 buys, last Aug 1, 2023
  • AKUS Akouos, Inc: 1 buy, last Jun 30, 2020
  • ETTX Entasis Therapeutics Holdings Inc: 1 buy, last Sep 28, 2018

Get free alerts when Pivotal bioVenture Partners Fund I L.P. files a new trade →